Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives

In the last decade, antibody-drug conjugates (ADCs), normally formed by a humanized antibody and a small drug via a chemical cleavable or non-cleavable linker, have emerged as a potential treatment strategy in cancer disease. They allow to get a selective delivery of the chemotherapeutic agents at t...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Cristina Martín-Sabroso, Irene Lozza, Ana Isabel Torres-Suárez, Ana Isabel Fraguas-Sánchez
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	auristatins cervical cancer endometrial cancer maytansinoids mirvetuximab soravtansine ovarian cancer
Online Access:	https://www.mdpi.com/1999-4923/13/10/1705